An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India

PURPOSE: A new oral formulation of itraconazole, called super bioavailable itraconazole (SBITZ), has been launched in India, exhibiting greater bioavailability than conventional itraconazole (CITZ). No clinical studies on its effectiveness and safety in dermatophytosis in comparison with CITZ have b...

Descripción completa

Detalles Bibliográficos
Autores principales: Shenoy, Manjunath, Dhoot, Dhiraj, Mahajan, Harshal, Barkate, Hanmant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485852/
https://www.ncbi.nlm.nih.gov/pubmed/34611418
http://dx.doi.org/10.2147/CCID.S326642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485852/
https://www.ncbi.nlm.nih.gov/pubmed/34611418
http://dx.doi.org/10.2147/CCID.S326642

Ejemplares similares